Display options
Cite
Mori Y, Sato H, Kumazawa T, et al. Analysis of radiotherapy-induced alteration of CD8. Oncol Lett. 2021;21(6):446doi: 10.3892/ol.2021.12707.
Mori, Y., Sato, H., Kumazawa, T., Permata, T. B. M., Yoshimoto, Y., Murata, K., Noda, S. E., Kaminuma, T., Ando, K., Oike, T., Okonogi, N., Okada, K., Kakoti, S., Suzuki, K., Ikota, H., Yokoo, H., Nakano, T., Ohno, T., & Shibata, A. (2021). Analysis of radiotherapy-induced alteration of CD8. Oncology letters, 21(6), 446. https://doi.org/10.3892/ol.2021.12707
Mori, Yasumasa, et al. "Analysis of radiotherapy-induced alteration of CD8." Oncology letters vol. 21,6 (2021): 446. doi: https://doi.org/10.3892/ol.2021.12707
Mori Y, Sato H, Kumazawa T, Permata TBM, Yoshimoto Y, Murata K, Noda SE, Kaminuma T, Ando K, Oike T, Okonogi N, Okada K, Kakoti S, Suzuki K, Ikota H, Yokoo H, Nakano T, Ohno T, Shibata A. Analysis of radiotherapy-induced alteration of CD8. Oncol Lett. 2021 Jun;21(6):446. doi: 10.3892/ol.2021.12707. Epub 2021 Apr 06. PMID: 33868484; PMCID: PMC8045163.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2021 Jun;21(6):446. doi: 10.3892/ol.2021.12707. Epub 2021 Apr 06.

Analysis of radiotherapy-induced alteration of CD8.

Oncology letters

Yasumasa Mori, Hiro Sato, Takuya Kumazawa, Tiara Bunga Mayang Permata, Yuya Yoshimoto, Kazutoshi Murata, Shin-Ei Noda, Takuya Kaminuma, Ken Ando, Takahiro Oike, Noriyuki Okonogi, Kohei Okada, Sangeeta Kakoti, Keiji Suzuki, Hayato Ikota, Hideaki Yokoo, Takashi Nakano, Tatsuya Ohno, Atsushi Shibata

Affiliations

  1. Department of Radiation Oncology, Graduate School of Medicine, Gunma University, Maebashi, Gunma 371-8511, Japan.
  2. Department of Radiotherapy, Saitama Cancer Center, Ina, Saitama 362-0806, Japan.
  3. Department of Radiation Oncology, Faculty of Medicine Universitas Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia.
  4. Department of Radiation Oncology, Fukushima Medical University, Fukushima 960-1247, Japan.
  5. Department of Radiation Oncology, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Saitama 350-1298, Japan.
  6. National Institute of Radiological Sciences, National Institute for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.
  7. Signal Transduction Program, Gunma University Initiative for Advanced Research, Gunma University, Maebashi, Gunma 371-8511, Japan.
  8. Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan.
  9. Clinical Department of Pathology, Gunma University Hospital, Maebashi, Gunma 371-8511, Japan.
  10. Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

PMID: 33868484 PMCID: PMC8045163 DOI: 10.3892/ol.2021.12707

Abstract

Radiotherapy induces an immune response in the cancer microenvironment that may influence clinical outcome. The present study aimed to analyse the alteration of CD8

Copyright © 2021, Spandidos Publications.

Keywords: CD8+ T cell; cervical cancer; immune modulation; programmed death-ligand 1; radiotherapy; tumor microenvironment

Conflict of interest statement

The authors declare that they have no competing interests.

References

  1. J Immunol. 2002 Nov 15;169(10):5538-45 - PubMed
  2. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12293-7 - PubMed
  3. Ther Adv Med Oncol. 2018 Jan 18;10:1758834017742575 - PubMed
  4. Obstet Gynecol Clin North Am. 2012 Jun;39(2):233-53 - PubMed
  5. Cancer Cell Int. 2019 May 23;19:146 - PubMed
  6. Radiother Oncol. 2016 Sep;120(3):428-433 - PubMed
  7. Cancer Immunol Immunother. 2013 Feb;62(2):203-16 - PubMed
  8. Ann Surg. 2018 Dec;268(6):992-999 - PubMed
  9. CA Cancer J Clin. 2018 Nov;68(6):394-424 - PubMed
  10. N Engl J Med. 1999 Apr 15;340(15):1144-53 - PubMed
  11. Clin Cancer Res. 2016 Nov 15;22(22):5553-5563 - PubMed
  12. Ann Surg Oncol. 2014 Jun;21 Suppl 3:S414-21 - PubMed
  13. Medicine (Baltimore). 2017 May;96(18):e6369 - PubMed
  14. Mod Pathol. 2017 Apr;30(4):577-586 - PubMed
  15. Nat Rev Cancer. 2016 May;16(5):275-87 - PubMed
  16. J Radiat Res. 2020 Mar 23;61(2):275-284 - PubMed
  17. Clin Cancer Res. 2010 Sep 15;16(18):4583-94 - PubMed
  18. Int J Biol Markers. 2020 Mar;35(1):65-73 - PubMed
  19. J Clin Oncol. 2008 Dec 10;26(35):5802-12 - PubMed
  20. PLoS One. 2009 Sep 10;4(9):e6982 - PubMed
  21. Oncotarget. 2016 Oct 25;7(43):70969-70978 - PubMed
  22. Am J Cancer Res. 2015 May 15;5(6):2064-74 - PubMed
  23. Int J Clin Oncol. 2020 May;25(5):801-809 - PubMed
  24. Lancet Oncol. 2019 Aug;20(8):e404-e416 - PubMed
  25. Br J Cancer. 2019 Sep;121(6):490-496 - PubMed
  26. Clin Cancer Res. 2009 Oct 15;15(20):6341-7 - PubMed
  27. N Engl J Med. 1999 Apr 15;340(15):1137-43 - PubMed
  28. Nat Commun. 2019 Sep 2;10(1):3959 - PubMed
  29. Int J Gynaecol Obstet. 2009 May;105(2):103-4 - PubMed
  30. PLoS One. 2014 Mar 31;9(3):e92572 - PubMed
  31. Crit Rev Oncol Hematol. 2017 May;113:63-70 - PubMed
  32. Nat Commun. 2017 Nov 24;8(1):1751 - PubMed
  33. Strahlenther Onkol. 2020 Aug;196(8):725-735 - PubMed
  34. Am J Obstet Gynecol. 2007 Nov;197(5):503.e1-6 - PubMed
  35. Immunol Lett. 2002 Oct 21;84(1):57-62 - PubMed
  36. Clin Cancer Res. 2015 Jun 1;21(11):2635-43 - PubMed
  37. Science. 2015 Apr 3;348(6230):56-61 - PubMed
  38. Clinics (Sao Paulo). 2018 Dec 10;73(suppl 1):e557s - PubMed
  39. J Clin Oncol. 2004 Mar 1;22(5):872-80 - PubMed

Publication Types